Expression and In vitro activity of recombinant canstatin in stably transformed bombyx mori cells

J Microbiol Biotechnol. 2009 Jul;19(7):685-9. doi: 10.4014/jmb.0808.468.

Abstract

We describe the expression of recombinant canstatin from stably transformed Bombyx mori Bm5 (Bm5) cells. Recombinant canstatin was secreted into a culture medium with a molecular mass of approximately 29 kDa. Densitometric scanning showed that the secreted canstatin accounted for approximately 91% of the total canstatin production. Recombinant canstatin was also purified to homogeneity using a simple one-step Ni-NTA affinity fractionation. The identity of the purified protein was confirmed as human canstatin by nano-LC-MS/MS analysis. Purified recombinant canstatin inhibited human endothelial cell proliferation in a dose-dependent manner. The concentration at half-maximum inhibition (ED50) for recombinant canstatin expressed in stably transformed Bm5 cells was approximately 0.64 mg/ml. A maximum production level of 11 mg/l recombinant canstatin was obtained in a T-flask culture of Bm5 cells after 6 days of incubation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Angiogenesis Inhibitors / administration & dosage
  • Angiogenesis Inhibitors / isolation & purification
  • Angiogenesis Inhibitors / metabolism
  • Animals
  • Bombyx
  • Cell Line
  • Cell Proliferation / drug effects
  • Collagen Type IV / administration & dosage
  • Collagen Type IV / isolation & purification
  • Collagen Type IV / metabolism*
  • Dose-Response Relationship, Drug
  • Endothelial Cells / drug effects
  • Endothelial Cells / physiology
  • Fractional Precipitation
  • Humans
  • Molecular Sequence Data
  • Peptide Fragments / administration & dosage
  • Peptide Fragments / isolation & purification
  • Peptide Fragments / metabolism*
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / isolation & purification
  • Recombinant Proteins / metabolism
  • Time Factors

Substances

  • Angiogenesis Inhibitors
  • COL4A2 protein, human
  • Collagen Type IV
  • Peptide Fragments
  • Recombinant Proteins